Fabio Marra
Overview
Explore the profile of Fabio Marra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
230
Citations
7371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burra P, Camma C, Invernizzi P, Marra F, Pompili M
Ann Hepatol
. 2025 Mar;
:101900.
PMID: 40089150
Aminotransferases, particularly alanine aminotransferase (ALT), are commonly used in the detection, diagnosis, and management of chronic liver diseases. ALT, a sensitive and cost-effective marker of liver injury, remains pivotal in...
2.
Stella L, Pallozzi M, Cerrito L, Santopaolo F, Tovoli F, Hollande C, et al.
Clin Gastroenterol Hepatol
. 2025 Feb;
PMID: 40020957
Background And Aims: Atezolizumab plus Bevacizumab (atezobeva) has changed the treatment landscape of advanced hepatocellular carcinoma (HCC), but its efficacy and safety in patients with impaired liver function are still...
3.
Pastore M, Giachi A, Spinola-Lasso E, Marra F, Raggi C
Front Cell Dev Biol
. 2025 Jan;
12():1536854.
PMID: 39850799
Liver cancer is a leading cause of cancer-related deaths worldwide, highlighting the need for innovative approaches to understand its complex biology and develop effective treatments. While traditional animal models have...
4.
Roccarina D, Saltini D, Adotti V, Rosi M, Senzolo M, Nardelli S, et al.
Hepatology
. 2025 Jan;
PMID: 39774529
Background And Aims: In clinical practice, the reduction of portocaval pressure gradient (PCPG) following TIPS does not always meet the recommendation of current guidance. We evaluated the impact of different...
5.
Porro N, Spinola-Lasso E, Pastore M, Caligiuri A, Di Tommaso L, Marra F, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766138
Among solid tumors, cholangiocarcinoma (CCA) emerges as one of the most difficult to eradicate. The silent and asymptomatic nature of this tumor, particularly in its early stages, as well as...
6.
Mannini A, Pastore M, Giachi A, Correnti M, Spinola Lasso E, Lottini T, et al.
Liver Int
. 2024 Dec;
45(1):e16208.
PMID: 39726234
Background & Aims: GD2, a member of the ganglioside (GS) family (sialic acid-containing glycosphingolipids), is a potential biomarker of cancer stem cells (CSC) in several tumours. However, the possible role...
7.
Lori G, Pastore M, Navari N, Piombanti B, Booijink R, Rovida E, et al.
JHEP Rep
. 2024 Oct;
6(10):101182.
PMID: 39430578
Background & Aims: Among the reprogrammed metabolic pathways described in cancer stem cells, aberrant lipid metabolism has recently drawn increasing attention. Our study explored the contribution of fatty acids (FA)...
8.
Ciufolini G, Zampieri S, Cesaroni S, Pasquale V, Bonanomi M, Gaglio D, et al.
Cells
. 2024 Sep;
13(18.
PMID: 39329720
Developing accurate in vitro models that replicate the in vivo tumor environment is essential for advancing cancer research and therapeutic development. Traditional 2D cell cultures often fail to capture the...
9.
Gitto S, Fiorillo C, Argento F, Fini E, Borghi S, Falcini M, et al.
Res Pract Thromb Haemost
. 2024 Sep;
8(6):102555.
PMID: 39309232
Background: Cardiovascular events represent a major cause of non-graft-related death after liver transplant. Evidence suggest that chronic inflammation associated with a remarkable oxidative stress in the presence of endothelial dysfunction...
10.
La Mura V, Cardinale V, De Cristofaro R, De Santis A, Di Minno G, Fabris L, et al.
Blood Adv
. 2024 Sep;
8(22):5725-5734.
PMID: 39226466
Adeno-associated virus-based gene therapy (valoctocogene roxaparvovec) is an attractive treatment for hemophilia A. Careful clinical management is required to minimize the risk of hepatotoxicity, including assessment of baseline liver condition...